Clayton’s Basic Pharmacology For Nurses Practice Exam

The essential idea is that drugs must prove their safety (and effectiveness) before they reach patients. The FDA reviews data from laboratory studies and clinical trials to determine whether the benefits of a new drug outweigh the risks, and to ensure the manufacturing process and labeling clearly communicate who should use the drug, how it’s dosed, and what risks to watch for. Only after this thorough premarketing evaluation is the drug approved for marketing. After approval, the FDA continues to monitor safety in the real world, but the question highlights the premarketing determination: the FDA is authorized to determine safety before a drug is marketed. The other statements don’t fit because the FDA is indeed involved in drug safety, it regulates more than just advertisements, and its primary premarketing role isn’t limited to post-market safety.